Skip to Main content Skip to Navigation
Journal articles

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

Complete list of metadatas

https://hal.uca.fr/hal-01639670
Contributor : Jeannette Ouertani <>
Submitted on : Monday, November 20, 2017 - 3:08:18 PM
Last modification on : Thursday, April 2, 2020 - 1:25:49 AM

Links full text

Identifiers

Citation

A. Amiot, M. Serrero, L. Peyrin-Biroulet, J. Filippi, B. Pariente, et al.. One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics (Suppl), 2017, 46 (3), pp.310 - 321. ⟨10.1111/apt.14167⟩. ⟨hal-01639670⟩

Share

Metrics

Record views

372